Passage Bio Announces Key Executive Appointments

Passage Bio

PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) recently announced three key leadership appointments. These experienced executives will support the company’s growth and further enhance the company’s clinical development capabilities in managing its robust pipeline.

Maria Törnsén joins Passage Bio as chief commercial officer, effective today. She reports to Passage Bio President and Chief Executive Officer Bruce Goldsmith, Ph.D., and is a member of the executive team. She is responsible for leading and building out the company’s commercial organization and strategy, including determining product positioning and paths to commercialization. Prior to joining Passage Bio, Ms. Törnsén, who has nearly 20 years of global commercial experience, was at Sarepta Therapeutics, where she was senior vice president, general manager, U.S.

Simona King will join Passage Bio as chief financial officer (CFO), effective August 23 She will report to Dr. Goldsmith and will be a member of the executive team. She will be responsible for finance, accounting, tax, treasury, investor relations functions and information technology. Ms. King, the former executive vice president and CFO at Tmunity Therapeutics, has more than 20 years of pharmaceutical and biotech strategic finance experience.

READ:  Police Search for Suspects Involved in Assault on Officers

Mark Forman, M.D., Ph.D., will join Passage Bio as chief medical officer, effective July 30. He will report to the Chief Research & Development Officer Eliseo Salinas, M.D., MSc., and will be responsible for leading the company’s translational and clinical development efforts. Dr. Forman has nearly two decades of experience in translational research for neurological disorders, having served as head of translational medicine at Acadia and translational research for neuroscience at Merck. He will join Passage Bio from the Alzheimer’s Drug Discovery Foundation (ADDF), where he oversaw the drug discovery and development portfolio.

“I’m thrilled that we are able to bring these highly experienced professionals to our company, enhancing our already talented leadership team,” Dr. Goldsmith said. “Passage Bio’s robust and expanding pipeline presents significant opportunity both in terms of clinical development and in commercial planning to ensure optimal patient adoption once our therapies are approved. I’m pleased that we have such strong leadership to expertly drive our company growth and advance our pipeline for patients.”

READ:  Hand & Stone Massage and Facial Spa Promotes John Teza to Chief Executive Officer

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.